The transwell assay results hinted that the rate of invaded nasopharyngeal carcinoma cells was dramatically decreased after sh-USP21#1 and sh-USP21#2 transfection (Figure 2(a)). The gene discussed is USP21; the disease is nasopharyngeal carcinoma.